Final Results -22-

+--------------------------------------+---+--------------+--+--------------+--+---------------+--+--------------+ 
|                                      |   |              |  |              |  |               |  |              | 
+--------------------------------------+---+--------------+--+--------------+--+---------------+--+--------------+ 
| (Loss) / earnings per share          |   | (93,692,121) |  |   1,479,910  |  | (101,615,095) |  |   1,002,138  | 
| attributable to the equity holders   |   |              |  |              |  |               |  |              | 
| of the Company during the year       |   |              |  |              |  |               |  |              | 
+--------------------------------------+---+--------------+--+--------------+--+---------------+--+--------------+ 
|                                      |   |              |  |              |  |               |  |              | 
+--------------------------------------+---+--------------+--+--------------+--+---------------+--+--------------+ 
| Weighted average number of ordinary  |   | 202,905,796  |  | 173,535,776  |  |  202,905,796  |  | 173,535,776  | 
| shares for the purposes of basic     |   |              |  |              |  |               |  |              | 
| earnings per share                   |   |              |  |              |  |               |  |              | 
+--------------------------------------+---+--------------+--+--------------+--+---------------+--+--------------+ 
|                                      |   |              |  |              |  |               |  |              | 
+--------------------------------------+---+--------------+--+--------------+--+---------------+--+--------------+ 
| Effect of dilutive potential         |   |              |  |              |  |               |  |              | 
| ordinary shares:                     |   |              |  |              |  |               |  |              | 
+--------------------------------------+---+--------------+--+--------------+--+---------------+--+--------------+ 
| Share options                        |   |           -  |  |   4,949,411  |  |            -  |  |   4,949,411  | 
+--------------------------------------+---+--------------+--+--------------+--+---------------+--+--------------+ 
|                                      |   |              |  |              |  |               |  |              | 
+--------------------------------------+---+--------------+--+--------------+--+---------------+--+--------------+ 
| Weighted average number of ordinary  |   | 202,905,796  |  | 178,485,187  |  |  202,905,796  |  | 178,485,187  | 
| shares for the purposes of diluted   |   |              |  |              |  |               |  |              | 
| earnings per share                   |   |              |  |              |  |               |  |              | 
+--------------------------------------+---+--------------+--+--------------+--+---------------+--+--------------+ 
 
 
 
 
21 Share based payments 
 
 
The Company operates an executive share option scheme for Directors and certain 
senior management. 
+--------------------------------------+---+----------+--+----------------+--+-----------+--+--------------+ 
|                                      |   |     2008 |  |           2008 |  |      2007 |  |         2007 | 
+--------------------------------------+---+----------+--+----------------+--+-----------+--+--------------+ 
|                                      |   |      GBP |  |            No. |  |       GBP |  |          No. | 
+--------------------------------------+---+----------+--+----------------+--+-----------+--+--------------+ 
|                                      |   | Weighted |  |                |  |  Weighted |  |              | 
|                                      |   |  average |  |                |  |   average |  |              | 
|                                      |   | exercise |  |                |  |  exercise |  |              | 
|                                      |   |    price |  |                |  |     price |  |              | 
+--------------------------------------+---+----------+--+----------------+--+-----------+--+--------------+ 
|                                      |   |          |  |                |  |           |  |              | 
+--------------------------------------+---+----------+--+----------------+--+-----------+--+--------------+ 
| Outstanding at beginning of year     |   |          |  |     4,430,000  |  |           |  |   4,430,000  | 
+--------------------------------------+---+----------+--+----------------+--+-----------+--+--------------+ 
| Granted during the year              |   |          |  |     8,065,000  |  |           |  |           -  | 
+--------------------------------------+---+----------+--+----------------+--+-----------+--+--------------+ 
| Exercised during the year            |   |          |  |   (12,245,000) |  |           |  |           -  | 
+--------------------------------------+---+----------+--+----------------+--+-----------+--+--------------+ 
| Lapsed during the year               |   |          |  |      (250,000) |  |           |  |           -  | 
+--------------------------------------+---+----------+--+----------------+--+-----------+--+--------------+ 
| Outstanding at end of year           |   |    0.001 |  |            -   |  |     0.001 |  |   4,430,000  | 
+--------------------------------------+---+----------+--+----------------+--+-----------+--+--------------+ 
 
 
 
 
All options vested during the year. The exercise price of all options 
outstanding as at 31 December 2007 was GBP0.001 per share. 
 
 
All shares were exercised on 17 July 2008. The share price at that date was 63 
pence. 
 
 
The weighted average fair value of options granted during the year was 47 pence 
(2007: no options granted). 
 
 
The following information is relevant in the determination of the fair value of 
options granted during the year (2007: no options granted) under the equity 
share option scheme operated by the Group. 
+--------------------------------------+---+----------+--+-----------+--+-----------+ 
|                                      |   |          |  |           |  |      2008 | 
+--------------------------------------+---+----------+--+-----------+--+-----------+ 
|                                      |   |          |  |           |  |       GBP | 
+--------------------------------------+---+----------+--+-----------+--+-----------+ 
| Option pricing model used            |   |          |  |           |  | QCA - IRS | 
|                                      |   |          |  |           |  |    Option | 
|                                      |   |          |  |           |  |     value | 
+--------------------------------------+---+----------+--+-----------+--+-----------+ 
| Weighted average share price at      |   |          |  |           |  |     0.855 | 
| grant date                           |   |          |  |           |  |           | 
+--------------------------------------+---+----------+--+-----------+--+-----------+ 
| Exercise price                       |   |          |  |           |  |     0.001 | 
+--------------------------------------+---+----------+--+-----------+--+-----------+ 
| Expected Life of Option (years)      |   |          |  |           |  |        3  | 
+--------------------------------------+---+----------+--+-----------+--+-----------+ 
|                                      |   |          |  |           |  |           | 
+--------------------------------------+---+----------+--+-----------+--+-----------+ 
| Expected dividend yield              |   |          |  |           |  |        2% | 
+--------------------------------------+---+----------+--+-----------+--+-----------+ 
| Expected volatility                  |   |          |  |           |  |        5% | 
+--------------------------------------+---+----------+--+-----------+--+-----------+ 
| Illiquid market discount             |   |          |  |           |  |       20% | 
+--------------------------------------+---+----------+--+-----------+--+-----------+ 
| Discount due to market performance   |   |          |  |           |  |       20% | 
| targets                              |   |          |  |           |  |           | 
+--------------------------------------+---+----------+--+-----------+--+-----------+ 
 
 
 
 
 
 
The Company recognised the following total expenses and costs in respect of 
equity settled share payments in the period. 
 
 
+--------------------------------------+---+----------+--+-----------+--+------------+--+------------+ 
|                                      |   |          |  |           |  |       2008 |  |       2007 | 
+--------------------------------------+---+----------+--+-----------+--+------------+--+------------+ 
|                                      |   |          |  |           |  |        GBP |  |        GBP | 
+--------------------------------------+---+----------+--+-----------+--+------------+--+------------+ 
| Recognised immediately as an expense and charged to |  |           |  | 6,043,952  |  | 1,207,248  | 
| Income statement                                    |  |           |  |            |  |            | 
+--------------------------------------+---+----------+--+-----------+--+------------+--+------------+ 
 
 
  22 Related parties 
 
 
In 2006, the Company entered into an Advisory Services agreement with the LLP. 
Under the agreement, the LLP was appointed Advisor for an initial period of 5 
years to provide investment advice to the Company. The annual management fee 
chargeable by the Advisor is currently based on a fee of 120 percent of the 
Advisor's budgeted costs for the year. 
 
 
In 2006, ACPIM, a wholly owned subsidiary of ACP, entered into an Investment 
Management Agreement with ACPM. Under the agreement, ACPIM was appointed 
Investment Manager for an initial period of 3 years and given discretion to 
manage the investment portfolio of ACPM subject to certain guidelines. The 
period of appointment was extended to 7 years starting in December 2007. The